Sponsorship Announcement

Here is the press release regarding my 2010 sponsorship:

Press Release

Charlie Kimball Secures Partnership with Novo Nordisk, Maker of the Levemir® FlexPen®, for 2010 Firestone Indy Lights Campaign

Indianapolis, IN and Princeton, NJ (February 24, 2010) -- California native Charlie Kimball has secured sponsorship from Novo Nordisk, a world leader in diabetes care. Kimball will pilot the No. 26 Levemir® FlexPen® car for AFS Racing/Andretti Autosport and will run a full 13-race schedule on the 2010 Firestone Indy Lights series.

Kimball, 25, is the only licensed racer with type 1 diabetes in the history of the Indy Racing League. Diagnosed in 2007, he monitors his blood sugar before, during and after each race, and uses Novo Nordisk insulin Levemir® (insulin detemir [rDNA origin] injection) and NovoLog® (insulin aspart [rDNA origin] injection). The partnership with Novo Nordisk includes primary sponsorship of Kimball’s race car, racing suit and helmet. Kimball also will make appearances on behalf of Novo Nordisk throughout 2010.

“Charlie Kimball is the perfect example of how people living with diabetes can successfully manage their disease without letting it get in the way of their dreams,” said Camille Lee, Vice President of Diabetes Marketing at Novo Nordisk. “We are proud of our association with Charlie and we look forward to a successful year on and off the track in 2010.”

Kimball will be competing in his second season in the Firestone Indy Lights series. In 2009, he finished 10th overall, posting a season-best fourth place at Watkins Glen and finishing the 2009 campaign with eight Top 10 results. The 2010 season includes the following race events in 13 cities across North America:

• March 28: Streets of St. Petersburg (St. Petersburg, Florida)
• April 11: Barber Motorsports Park (Birmingham, Alabama)
• April 18: Streets of Long Beach (Long Beach, California)
• May 28: Indianapolis Motor Speedway (Indianapolis, Indiana)
• June 19: Iowa Speedway (Newton, Iowa)
• July 4: Watkins Glen International (Watkins Glen, New York)
• July 18: Streets of Toronto (Toronto, Ontario, Canada)
• July 25: Edmonton City Centre Airport (Edmonton, Alberta, Canada)
• Aug. 8: Mid-Ohio Sports Car Course (Toledo, Ohio)
• Aug. 22: Infineon Raceway (Sonoma, California)
• Aug. 28: Chicagoland Speedway (Chicago, Illinois)
• Sept. 4: Kentucky Speedway (Louisville, Kentucky)
• Oct. 2: Homestead-Miami Speedway (Miami, Florida)

“This is a big year for me and expectations are high,” Kimball said. “I am fortunate to not only be part of one of the top teams in all of racing at AFS Racing/Andretti Autosport, but to have the support of Novo Nordisk, one of the world’s leading healthcare companies that is committed to helping me live my dream.”

Kimball launched his single-seater racing career in 2002 and has raced in several international series since then, highlighted by a five-win effort in the 2005 British Formula 3 Championship. At that time, Kimball established himself as the first American to win a British Formula 3 race in 11 years.

Prescribing information for Levemir® and NovoLog® is available by contacting Novo Nordisk at 1-800-727-6500 or visiting Levemir-us.com and NovoLog.com.

About Levemir® and NovoLog®
Levemir® (insulin detemir [rDNA origin] injection) is a man-made long-acting insulin that is used to control high blood sugar in adults and children with diabetes mellitus.

NovoLog® (insulin aspart [rDNA origin] injection) is a man-made insulin that is used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information for Levemir®
Do not take Levemir® if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in Levemir®. If you take too much Levemir® your blood sugar may fall too low.

Check your blood sugar levels. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take Levemir®.

Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin.

Never mix Levemir® with other insulin products or use in an insulin pump.

Needles and Levemir® FlexPen® must not be shared.

Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your Levemir® dose may change if you take other medicines.

The most common side effect of Levemir® is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information.

Important Safety Information for NovoLog®
Do not take NovoLog® if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in NovoLog®. If you take too much NovoLog® your blood sugar may fall too low.

NovoLog® is a fast-acting insulin. You should eat a meal within 5 to 10 minutes after using NovoLog® to avoid low blood sugar. Do not inject NovoLog® if you do not plan to eat right after using NovoLog®. Check your blood sugar levels. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take NovoLog®.

Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin.

Do not mix NovoLog® with any other insulins when used in a pump or with any insulins other than NPH when used with injections by syringe.

Needles and NovoLog® FlexPen® must not be shared.

Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your NovoLog® dose may change if you take other medicines.

NovoLog® has not been studied in children with type 2 diabetes or in children with type 1 diabetes under the age of two.

The most common side effect of NovoLog® is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information.

FlexPen®, Levemir®, and NovoLog® are registered trademarks of Novo Nordisk A/S.

# # #

About Charlie Kimball
Kimball, who began racing go-karts at age nine, was accepted into Stanford University and chose to bypass admission to follow his dream to become a racecar driver. Prior to his diabetes diagnosis in 2007, Kimball shattered the European stereotype that “Americans are not fast” by becoming the first American in 11 years to win a British Formula 3 race. He went on to secure two track records and several F3 victories in both Britain and Europe. Kimball has also raced in the Formula 3 Euroseries and the World Series by Renault. This year, Kimball will be competing in the Firestone Indy Lights races throughout the year.

For additional information about Charlie Kimball, visit www.charliekimball.com.
Follow Charlie on Twitter at http://twitter.com/racewithinsulin, on his blog, www.CharlieKimball.blogspot.com, on YouTube, at www.youtube.com/charliekimball, and via the Charlie Kimball Fan Club on Facebook.

About Andretti Autosport
Based in Indianapolis, IN, Andretti Autosport is led by racing legend Michael Andretti. Andretti Autosport, which is the winningest team in Indy Racing League history, fields multiple entries in the IZOD IndyCar Series and also campaigns multiple cars in Firestone Indy Lights in a joint venture with AFS Racing. Andretti Autosport boasts three IZOD IndyCar Series championships (2004, 2005 and 2007), two Firestone Indy Lights titles (2008 and 2009) and has won the Indianapolis 500 twice (2005 and 2007). For more information, please visit www.andrettiautosport.com.

About Novo Nordisk
Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. Headquartered in Denmark, Novo Nordisk employs more than 29,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk’s B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk-us.com.

About Diabetes
In the United States one in 13, or 23.6 million people, have diabetes, a condition in which the body does not produce or properly use insulin, the hormone needed to convert sugar, starches and other food into energy needed for daily life. Poorly or untreated diabetes can lead to a long list of health complications such as heart disease, stroke, kidney disease, high blood pressure, blindness, nerve problems and amputations.



For further information please contact:

Media:
Al Larsen
Andretti Autosport
317-872-2700
al.larsen@andrettiautosport.com

Ambre Morley
Novo Nordisk
609-514-8400
abmo@novonordisk.com

Investors:
Hans Rommer
Novo Nordisk
+45-444-24765
hrmm@novonordisk.com

Transcript from IZOD Indy Car Teleconference

Yesterday, I took part in the weekly IZOD Indy Car Series Teleconference. Here is the transcript from my portion of that! Thank you to the IRL PR/ Media department for having me on the call.

Charlie, thanks for joining us.

CHARLIE KIMBALL: Thanks for having me.

THE MODERATOR: Charlie finished 10th in his rookie season in Firestone Indy Lights last year with Team PBIR, but moves to AFS/Andretti Autosport, the team and car that won last year's title.

Q. Do you feel much pressure entering the season going into that car and that team?

CHARLIE KIMBALL: Well, I think I always put more pressure on myself than I feel externally. Obviously, jumping in the No. 26 car means that I know I've got some of the best equipment out there. At the end of the day, it comes down to me to perform. I think that testing has been going really well. I'm really excited. The crew is a lot of fun to work with. I can't wait to get to the open test next week and the first race at St. Pete.

Q. You mentioned you tested with the team. What have you learned about yourself and the team going into next week's test at Barber, which is essentially like a race weekend?

CHARLIE KIMBALL: You're right, going into Barber, we're sort of treating it like our first competition. There's no prizes or rewards for results at Barber, but it's a chance for us to unveil the new paint scheme for the No. 26 Levemir(r) car. We have a line item list of stuff to test. Hopefully we'll end the day near the top of the charts.

I've learned a lot this year just about how a professional team works. Stepping into Andretti, having someone like Michael Andretti with his hand on the tiller, giving me the benefit of his experience has allowed me to learn a lot more quickly than I have in the past.

Q. The test is at Barber Motorsports Park. Have you been there? What are your thought on that facility?

CHARLIE KIMBALL: I actually did a test day at Andretti/AFS Racing last fall down at Barber. I thoroughly enjoyed it. It was surprising how much fun it is. It's very technical and pretty quick in places. It's got a really good mix. I think it benefits a driver that's on top of it as well as a good car.

So not only am I looking forward to the test next week, but also to the second race of the season.

Q. You mentioned your sponsor. You're the first Indy Racing League driver to compete with Type 1 diabetes. Does being diabetic affect the way you go racing?

CHARLIE KIMBALL: Having diabetes definitely affects how I prepare to get in the car. From the moment I get up in the morning, before a test day or a race day, I'm preparing. I'm checking by blood glucose levels. I'm injecting Levemir(r) and NovoLog(r), the two insulins I use as needed. Everything is getting ready for the moment I put my helmet on. I check my blood glucose level 15 minutes, 10 minutes, five minutes before I get in the car. It's the last thing I do before I put my gloves on.

That management routine allows me to go out and compete on a test day or race day equally and not have to worry about the diabetes.

Q. Can you talk a little bit about what your sponsor does using your car as a platform?

CHARLIE KIMBALL: A lot of what Novo Nordisk, the company that makes Levemir and NovoLog, the two insulins on the car do, the at‑the‑track promotion, telling my story as the first driver in the history of the IRL with diabetes to compete. But we also do a lot of at‑event appearances, the ADA, the American Diabetes Association, expos, where people come and are there to educate themselves about diabetes and hear my story, talk to me, interact with me.

I'm there proving that diabetes doesn't have to slow you down. It doesn't slow me down on the track or off the track. Together, partnering with them allows me to get that story out there and be proof that you don't have to have diabetes in the drivers seat; it can be in the passenger seat while you drive your life.

Q. Charlie, how did all of this come about with Andretti Racing?

CHARLIE KIMBALL: Well, funnily enough, it started with a phone call at 4 in the morning on a Wednesday before a race weekend in October of 2008. I was here in California at home. I got a call from Andretti about their program in the A1 GP, the Team USA car. They asked if I would come to Zandvoort, in The Netherlands, for a last‑minute drive in the race that weekend. Like five hours later, I was on a plane from LAX headed to Europe. I had a great time. It was a really good opportunity to work with them.

We just sort of kept in contact. After my results last year, developing the team, the results throughout the season, we kept in contact. As my commercial package fell into place, the discussions with Andretti led to a ride.

Q. How is Michael to work for?

CHARLIE KIMBALL: He's a brilliant guy. His experience all over the world in racecars everywhere allows me to learn a tremendous amount. He is always there with a word of encouragement, a word of advice, and very helpful for a young driver hoping to make it to the Izod IndyCar Series and the Indianapolis 500.

Q. Charlie, did you have to convince people when you were starting out in racing that you could do this with diabetes and still manage it? Also, the notes say that you're able to monitor your blood sugar during the race and adjust it if necessary. How does that work exactly?

CHARLIE KIMBALL: Well, I'll hit your first question first.

I was diagnosed in October of 2007, so in the middle of a race season. I'd already been racing. The road back to recovery, it was about six weeks before I got back in a racecar. In that time, you know, I sought out the best medical care. I work with an endocrinologist here in LA, Dr. Anne Peters, who is Gary Hall, Jr., the swimmer's, endocrinologists, as well.

So her experience with athletes gave me the confidence to get back in the car and be able to compete.

So I have found a huge amount of support in the racing community. The IRL, the medical staff there at the IRL and IMS medical team, has said to me, Look, you obviously know a lot about diabetes and diabetes management. Pardon the pun, but we'd love for you to be in the vehicle for you to tell your story, being successful with diabetes.

As far as managing my blood glucose and monitoring that through the race, I wear a continuous glucose monitor, which is a sensor injected in my body and has a wireless transmitter on my skin that looks like a pager‑like device that's Velcro'd to the steering wheel right under my dash. It graphs might blood sugar every five minutes and gives me a reading so I can keep an eye on that while I'm driving. If I'm getting lower than I want to be, I can drink orange juice that runs through a drink tube that runs through my helmet. Orange juice is very glucose rich so it brings my sugar levels back up to a range where I can compete at optimal performance.

Q. What is some of your background? Where have you been racing?

CHARLIE KIMBALL: Well, I started karting in Southern California when I was about 10, in '95. Got into cars at the age of 16. After I graduated high school in 2003, at the end of the 2003 season where I competed in the USS 2000 championship, I delayed entry or deferred admission to Stanford University to move to Europe and race, where I competed in British Formula Ford, British Formula 3. I was the first American in 13 years to win a British Formula 3 race, was Rookie‑of‑the‑Year. 2006 I stepped up to the Formula 3 Euro Series, where I won a race at Zandvoort. In 2007 I was racing in the World Series by Renault when I was diagnosed with diabetes in October of that year. 2008 I did a partial season in the Formula 3 Europe Series. And last year I competed in the Firestone Indy Lights Series with Team PBIR.

I got started in karting because my dad is a mechanical engineer. The car he designed won the Indianapolis 500 in the late '70s. I was in Europe as a kid because he was race engineering for a Formula One team.

Q. I wanted to know if you have, stepping into big shoes at Andretti, is there a timetable before you make the next step to the Izod IndyCar Series and what would you be looking for in terms of what you would call a successful season this year in Firestone Indy Lights?

CHARLIE KIMBALL: Well, I think I have to judge this season by the same yardstick that any good driver does. A good season would be one where I sit on pole for every race, have the fastest lap, win every race and win the championship. Obviously that might not be completely realistic.

But, like you said, I have some big shoes to fill in the No. 26 car. I think I can step up to that. My experience last year, I learned a huge amount about racing on the ovals, learned a lot of the tracks. So coming back to them, it will be my second year seeing them. I'll be able to leverage that into solid results.

As far as the timetable stepping up to the Izod IndyCar Series, obviously it comes down to partially commercial, partially on track. If I can provide the results this year and sort of prove my worth, Novo Nordisk believes that we can be the first driver on the grid at the Indianapolis 500 with diabetes.

THE MODERATOR: That's all the time we have today for Charlie. We appreciate you taking the time to join us today, Charlie.

CHARLIE KIMBALL: Absolutely. If anyone has any follow‑up questions, have them get in touch with you.

THE MODERATOR: Thanks, Charlie.

Meeting up in Mammoth

I have been very remiss in blogging recently. I have been busy, but that is not a good enough excuse! Here is a blog I wrote about a week and a half ago from a snowboarding trip to Mammoth.

A couple of weekends ago, a few friends and I went up to Mammoth Mountain for a few days of snowboarding and skiing. One of my high school friends is working as a lift operator at June Mountain and since the schedules worked out, I was looking forward to hanging out with him. The first of California’s ‘El Nino’ storms had come through the week before and Mammoth got a lot of snow. Like 10 feet of fresh powder! It was a lot of fun and I thoroughly enjoyed the three days on the mountain. I thoroughly enjoyed some time ‘disconnected’ from the racing world especially as we get towards the busy time of year.

There was however a really interesting chance encounter at lunch on the first day of skiing. Two friends and I headed to Main Lodge to grab some food, warm up and check the score of the AFC Championship game. I had just gotten my food and was sitting down to eat when I grabbed my blood glucose meter to check my blood sugar after a morning of riding and before lunch. As soon as I tested, I heard from a little boy, “do you have diabetes?” I responded with an affirmative and he said he did as well. Then his mom came up and we started a conversation. Turns out they are from the LA area as well and she is head of the local JDRF chapter. He was the coolest little boy, wears a pump and was getting a medal for a competition in the snowboard half pipe school. In the course of the conversation with his mother, it came up that she had heard my endocrinologist, Dr. Anne Peters, speak at a conference. We talked about what I do for a living to which she replied, “wait, you are her racing driver with your CGM on your steering wheel?! What are the odds!”


There are times when I feel very alone with diabetes and it can be a real struggle. Remembering conversations like that one with the little boy in the Main Lodge of Mammoth really helps remind me that I am not alone. Having diabetes makes me a part of a great community full of amazing people. It is a great way to remind myself that while I am racing because it is what I love to do, it is also a great inspiration to a lot of people.